IJCS | Volume 32, Nº4, July/August 2019

395 testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8(8):1308-39. 5. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/ EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-63. 6. Maron BJ, Zipes DP. 36th Bethesda Conference: Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45(8):1313-75. 7. Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422-45. 8. Heidbuchel H, Corrado D, Biffi A, Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil. 2006;13(5):676-86. 9. McAllister DR, Motamedi AR, Hame SL, Shapiro MS, Dorey FJ. Quality of life assessment in elite collegiate athletes. Am J Sports Med. 2001;29(6):806-10. 10. Rahman B, Macciocca I, Sahhar M, Kamberi S, Connell V, Duncan RE. Adolescents with implantable cardioverter defibrillators: a patient and parent perspective. Pacing Clin Electrophysiol. 2012;35(1):62-72. 11. Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter-defibrillators: A survey of Heart Rhythm Society Members. J Cardiovasc Electrophysiol. 2006;17(1):11-5. 12. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, et al. Safety of sports for athletes with implantable cardioverter- defibrillators: results of a prospective, multinational registry. Circulation. 2013;127(20):2021-30. 13. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, et al. Safety of sports for athletes with implantable cardioverter- defibrillators: long-term results of a prospective multinational registry. Circulation. 2017;135(23):2310-2. 14. Saarel EV, Law I, Berul CI, Ackerman MJ, Kanter RJ, Sanatani S, et al. Safety of sports for young patients with implantable cardioverter- defibrillators. Circ Arrhythm Electrophysiol. 2018;11(11):e006305. 15. Heidbuchel H, Willems R, Jordaens L, Olshansky B, Carre F, Lozano IF, et al. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort. Eur J Prev Cardiol. 2019;26(7):764-75. 16. Maron BJ. The paradox of exercise. N Engl J Med. 2000;343(19):1409-11. 17. Lampert R, Soufer R, McPherson CA, Batsford WP, Tirado S, Earley C, et al. Implantable cardioverter-defibrillator shocks increase T-wave alternans. J Cardiovasc Electrophysiol. 2007;18(5):512-7. 18. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators. Circulation. 2002;105(5):589-594. 19. OlshanskyB,AtteyaG,CannomD,HeidbuchelH,SaarelEV,AnfinsenOG, et al. Competitive athletes with implantable cardioverter defibrillators: How to program? Data from the Implantable CardioverterDefibrillator Sports Registry. Heart Rhythm. 2019;16(4):581-7 20. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in Inappropriate Therapy and Mortality through ICD Programming. N Eng J Med. 2012;367(24):2275-83. 21. Zipes DP, Link MS, Ackerman MJ, Kovacs RJ, Myerburg RJ, Estes NA. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e315-25. 22. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schäfers M, Zellerhoff S, et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation .2006;114:1799-806. 23. Cruz FM, Sanz-Rosa D, Roche-MolinaM, García-Prieto J, García-Ruiz JM, Pizarro G, et al. Exercise Triggers ARVC Phenotype in Mice Expressing a Disease-Causing Mutated Version of Human Plakophilin-2. J AmColl Cardiol. 2015;65(14):1438-50. 24. James CA, Bhonsale A, Tichnell C, Murra yB, Russell SD, Tandri H, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy- associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62(14):1290-7. 25. Rojas A, Calkins H. Present understandingoftherelationship between exercise andarrhythmogenicrightventricular dysplasia/cardiomyopathy. Trends Cardiovasc Med. 2015;25(3):181-8. 26. Konhilas JP, Watson PA, Maass A, Boucek DM, Horn T, Stauffer BL, et al. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res. 2006;98(4):540-8. 27. Saberi S, Wheeler M, Bragg-Gresham J, Hornsby W, Agarwal PP, Attili A, et al. Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial. JAMA. 2017;317(13):1349-57. 28. Sy RW, GollobMH, KleinGJ, Yee R, Skanes AC, Gula LJ, et al. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2011;8(6):864-71. 29. Ostby SA, Bos JM, Owen HJ, Wackel PL, Cannon B, Ackerman MJ. Competitive Sports Participation in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia. JACC Clin Electrophysiol. 2016;2(3):253-62. 30. Rice SG; American Academy of Pediatrics Council on Sports Medicine and Fitness. Medical conditions affecting sports participation. Pediatrics. 2008;121(4):841-8. 31. Kramer DB, Maisel WH. Guidelines for managing pacemaker and implantable defibrillator advisories. In: Ellenbogen KA, ed. Clinical cardiac pacing, defibrillation, and resynchronization therapy. Philadelphia: Elsevier Saunders; 2011. 32. Baggish AL, Ackerman MJ, Lampert R. Competitive Sport Participation Among Athletes With Heart Disease: A Call for a Paradigm Shift in Decision Making. Circulation. 2017;136(17):1569-71. 33. Barry MJ, Edgman-Levitan S. Shared decision making — The pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-781. Lampert Sports participation for athletes with ICDs Int J Cardiovasc Sci. 2019;32(4):391-395 Review Article This is an open-access article distributed under the terms of the Creative Commons Attribution License